• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯达曼地区公众对药品信息、安全性及药品不良反应(ADR)报告的认知情况。

Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia.

作者信息

Islam Md Ashraful, Al-Karasneh Aseel Fuad, Naqvi Atta Abbas, AlShayban Dhfer Mahdi, Al-Hayek Fatimah, Al-Badrani Sarah, Al-Salem Raghad, Ghori Syed Azizullah

机构信息

Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.

College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.

出版信息

Pharmacy (Basel). 2020 Nov 18;8(4):222. doi: 10.3390/pharmacy8040222.

DOI:10.3390/pharmacy8040222
PMID:33218152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7712078/
Abstract

This study aimed to assess public knowledge about medicine information, safety, and adverse drug reaction reporting (ADR) in Dammam, Saudi Arabia. A cross sectional study was conducted using purposive stratified sampling in different settings of Dammam city for three months (January-March 2020). The target population was identified as consumers who had used the medicines in the last 3 months. The questionnaire was adopted from the literature and was validated. Content and face validities were established, and reliability was assessed. The study was approved by the concerned ethics committee. A total of 915 participants returned completed questionnaires. A total of 54.4% participants aged between 18 and 30 years, 65.8% were females and 53.1% had obtained bachelor level education. The mean score for knowledge of medicines (K1) was 5.46 ± 1.07. The mean score for knowledge regarding medication safety (K2) was 5.94 ± 1.73. The mean score for tendency to report a suspected ADR (T1) was 3.43 ± 1.57. Gender was a determinant of knowledge regarding medication safety (K2) ( < 0.01) and ADR reporting tendency (T1) ( < 0.01). The marital status of patients was a determinant for both knowledge of medicines (K1) ( < 0.01) and, knowledge regarding medication safety (K2) ( < 0.01). The results of this study highlighted that although the scores for knowledge of medicines, and tendency to report ADR were better, the score for knowledge regarding medication safety was unsatisfactory.

摘要

本研究旨在评估沙特阿拉伯达曼市公众对药品信息、安全性及药品不良反应报告(ADR)的了解情况。采用目的分层抽样法,在达曼市不同场所进行了为期三个月(2020年1月至3月)的横断面研究。目标人群确定为过去3个月内使用过药品的消费者。问卷源自文献并经过验证。建立了内容效度和表面效度,并评估了信度。该研究获得了相关伦理委员会的批准。共有915名参与者返回了完整的问卷。共有54.4%的参与者年龄在18至30岁之间,65.8%为女性,53.1%拥有本科学历。药品知识(K1)的平均得分为5.46±1.07。用药安全知识(K2)的平均得分为5.94±1.73。报告疑似药品不良反应倾向(T1)的平均得分为3.43±1.57。性别是用药安全知识(K2)(<0.01)和药品不良反应报告倾向(T1)(<0.01)的决定因素。患者的婚姻状况是药品知识(K1)(<0.01)和用药安全知识(K2)(<0.01)的决定因素。本研究结果强调,尽管药品知识得分和药品不良反应报告倾向较好,但用药安全知识得分并不理想。

相似文献

1
Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia.沙特阿拉伯达曼地区公众对药品信息、安全性及药品不良反应(ADR)报告的认知情况。
Pharmacy (Basel). 2020 Nov 18;8(4):222. doi: 10.3390/pharmacy8040222.
2
Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.沙特阿拉伯达曼医疗保健人员对药物警戒及药品不良反应报告流程的知识、实践与态度
Curr Drug Saf. 2018;13(1):21-25. doi: 10.2174/1574886313666171218123802.
3
Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey.沙特本科药学专业学生对药物警戒和药品不良反应报告的看法:一项全国性调查。
Curr Pharm Teach Learn. 2017 Sep;9(5):779-785. doi: 10.1016/j.cptl.2017.05.016. Epub 2017 Jun 30.
4
Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.沙特阿拉伯医院医护人员对药物警戒的认知与态度。
Int J Clin Pharm. 2015 Dec;37(6):1104-10. doi: 10.1007/s11096-015-0165-5. Epub 2015 Jul 28.
5
Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.沙特阿拉伯利雅得市公众对药品不良反应报告的认知与看法。
Saudi Pharm J. 2017 Sep;25(6):868-872. doi: 10.1016/j.jsps.2017.01.004. Epub 2017 Jan 25.
6
Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.沙特阿拉伯社区药剂师关于不良反应报告的知识、行为和经验。
Saudi Pharm J. 2014 Nov;22(5):411-8. doi: 10.1016/j.jsps.2013.07.005. Epub 2013 Aug 21.
7
Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia.沙特阿拉伯一家三级护理医院医生对药物不良反应报告的认知与障碍
Hosp Pharm. 2021 Aug;56(4):368-373. doi: 10.1177/0018578720910385. Epub 2020 Mar 4.
8
Pharmacovigilance Perception and Knowledge Among Pharmacists and Interns in Saudi Arabia.沙特阿拉伯药剂师和实习生的药物警戒认知与知识
Risk Manag Healthc Policy. 2020 Jan 24;13:55-61. doi: 10.2147/RMHP.S241265. eCollection 2020.
9
Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.患者对药物不良反应(ADR)的报告:公众认知及报告信心预测因素的调查
Ther Innov Regul Sci. 2018 Nov;52(6):757-763. doi: 10.1177/2168479017745025. Epub 2018 Mar 1.
10
Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.有利于沙特阿拉伯药剂师报告药物不良反应的因素。
Expert Opin Drug Saf. 2019 Aug;18(8):745-752. doi: 10.1080/14740338.2019.1632287. Epub 2019 Jul 11.

引用本文的文献

1
Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia.沙特阿拉伯普通人群对药物警戒的知识、态度和实践以及报告药物不良反应的障碍
Risk Manag Healthc Policy. 2024 Oct 29;17:2557-2572. doi: 10.2147/RMHP.S484223. eCollection 2024.
2
Development and validation of a nomogram to predict medication risk based on a knowledge, attitude and practice (KAP) survey of residents in Shanxi Province, China.基于对中国山西省居民的知识、态度和实践(KAP)调查,开发并验证用于预测用药风险的列线图。
Front Pharmacol. 2024 Apr 17;15:1302274. doi: 10.3389/fphar.2024.1302274. eCollection 2024.
3
A Cross-Sectional Evaluation of Knowledge of Medicine Safety and Frequency of Reading Medication Leaflets and Its Predictors - Insights from Saudi Adults in Riyadh, Saudi Arabia.一项关于药物安全知识、阅读药品说明书频率及其预测因素的横断面评估——来自沙特阿拉伯利雅得成年居民的见解
Int J Gen Med. 2024 Jan 19;17:175-186. doi: 10.2147/IJGM.S446041. eCollection 2024.
4
Public awareness regarding the manufacturer provided information about medicine usage, safety, and adverse drug reactions in Balochistan, Pakistan.巴基斯坦俾路支省公众对药品制造商提供的药品使用、安全性及药物不良反应信息的认知情况。
Front Pharmacol. 2023 Jul 20;14:1190741. doi: 10.3389/fphar.2023.1190741. eCollection 2023.
5
Assessment of self-medication practice and the potential to use a mobile app to ensure safe and effective self-medication among the public in Saudi Arabia.沙特阿拉伯公众自我药疗行为评估以及使用移动应用程序确保公众安全有效自我药疗的潜力。
Saudi Pharm J. 2022 Jul;30(7):927-933. doi: 10.1016/j.jsps.2022.05.010. Epub 2022 May 30.

本文引用的文献

1
Patient Satisfaction and Their Willingness to Pay for a Pharmacist Counseling Session in Hospital and Community Pharmacies in Saudi Healthcare Settings.沙特医疗环境中患者对医院和社区药房药剂师咨询服务的满意度及其付费意愿。
Front Pharmacol. 2020 Mar 2;11:138. doi: 10.3389/fphar.2020.00138. eCollection 2020.
2
What can we learn from the public's understanding of drug information and safety? A population survey.我们能从公众对药物信息和安全性的理解中学到什么?一项人口调查。
Int J Pharm Pract. 2019 Feb;27(1):96-104. doi: 10.1111/ijpp.12458. Epub 2018 May 17.
3
Saudi Vigilance Program: Challenges and lessons learned.沙特阿拉伯警戒计划:挑战与经验教训
Saudi Pharm J. 2018 Mar;26(3):388-395. doi: 10.1016/j.jsps.2018.01.002. Epub 2018 Jan 4.
4
Assessment of Drug Information Service in Public and Private Sector Tertiary Care Hospitals in the Eastern Province of Saudi Arabia.沙特阿拉伯东部省公立和私立三级护理医院的药物信息服务评估
Pharmacy (Basel). 2017 Jul 4;5(3):37. doi: 10.3390/pharmacy5030037.
5
Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.沙特阿拉伯利雅得市公众对药品不良反应报告的认知与看法。
Saudi Pharm J. 2017 Sep;25(6):868-872. doi: 10.1016/j.jsps.2017.01.004. Epub 2017 Jan 25.
6
The value of patient reporting to the pharmacovigilance system: a systematic review.患者向药物警戒系统报告的价值:一项系统评价
Br J Clin Pharmacol. 2017 Feb;83(2):227-246. doi: 10.1111/bcp.13098. Epub 2016 Oct 12.
7
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.消费者准备好参与药物警戒系统了吗?——一项关于药品不良反应报告的葡萄牙初步研究。
Eur J Clin Pharmacol. 2015 Jul;71(7):883-90. doi: 10.1007/s00228-015-1867-2. Epub 2015 May 26.
8
Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.药品不良反应报告不足:印度药物警戒面临的一项挑战。
Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71. doi: 10.4103/0253-7613.150344.
9
Survey of patients' experiences and their certainty of suspected adverse drug reactions.患者对疑似药物不良反应的经历及其确定性调查。
Int J Clin Pharm. 2015 Feb;37(1):168-74. doi: 10.1007/s11096-014-0060-5. Epub 2015 Jan 10.
10
Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.沙特阿拉伯社区药剂师关于不良反应报告的知识、行为和经验。
Saudi Pharm J. 2014 Nov;22(5):411-8. doi: 10.1016/j.jsps.2013.07.005. Epub 2013 Aug 21.